Publication:
The impact of Thai multidisciplinary smoking cessation program on clinical outcomes: A multicentre prospective observational study

dc.contributor.authorChaisai C.
dc.contributor.authorThavorn K.
dc.contributor.authorWattanasirichaigoon S.
dc.contributor.authorRungruanghiranya S.
dc.contributor.authorThongphiew A.
dc.contributor.authorDilokthornsakul P.
dc.contributor.authorLee S.W.H.
dc.contributor.authorChaiyakunapruk N.
dc.date.accessioned2022-12-14T03:17:19Z
dc.date.available2022-12-14T03:17:19Z
dc.date.issued2022
dc.date.issuedBE2565
dc.description.abstractIntroduction: Tobacco use is the leading preventable cause of morbidity and mortality worldwide. Since 2010, Thailand has implemented a multidisciplinary smoking cessation clinic, which provides smoking cessation services, but the effectiveness of the clinics was not formally evaluated. This study was conducted to assess the real-world effectiveness of this multidisciplinary smoking cessation program. Methods: We conducted a prospective, multicentre, observational study on Thai participants aged 13 years and older in 24 smoking cessation clinics across Thailand's 13 health regions. Each clinic offered smoking cessation interventions according to the well-established 5As model for smoking cessation (Ask, Advise, Assess, Assist, and Arrange). Outcomes of interest were continuous abstinence rates (CAR) at 3 and 6 months. Biochemical confirmation and self-reporting were used to assess the outcomes. Descriptive statistics (mean, SD, median, IQR, and percentage) were used to analyze the smoking cessation outcomes in both intention-to-treat and per-protocol analysis approaches. Results: Smokers receiving services from the Thai multidisciplinary smoking cessation clinics had CAR of 17.49 and 8.33% at 3 and 6 months, respectively. For those with cardiovascular disease (CVD) or cerebrovascular disease, CAR was found to be 26.36% at 3 months and 13.81% at 6 months. While participants with chronic obstructive pulmonary disease (COPD) had CAR ranging from 32.69% at 3 months to 17.31% at 6 months. Conclusion: The multidisciplinary team smoking cessation clinic was effective in assisting smokers in quitting smoking. The effectiveness of the clinic was more pronounced for smokers with CVD, cerebrovascular disease, or COPD. Findings from this study support a decision to include multidisciplinary smoking cessation clinics in the universal health care benefits package. Copyright © 2022 Chaisai, Thavorn, Wattanasirichaigoon, Rungruanghiranya, Thongphiew, Dilokthornsakul, Lee and Chaiyakunapruk.
dc.format.mimetypeapplication/pdf
dc.identifier.citationPediatrics and Neonatology. Vol 63, No.5 (2022), p.489-495
dc.identifier.doi10.3389/fpubh.2022.965020
dc.identifier.issn22962565
dc.identifier.urihttps://hdl.handle.net/20.500.14740/10048
dc.language.isoeng
dc.publisherFrontiers Media S.A.
dc.rights.holderScopus
dc.subject.otherHealth policy
dc.subject.otherProgram evaluation
dc.subject.otherSmoking
dc.subject.otherSmoking cessation
dc.subject.otherTobacco
dc.titleThe impact of Thai multidisciplinary smoking cessation program on clinical outcomes: A multicentre prospective observational study
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85137690223&doi=10.3389%2ffpubh.2022.965020&partnerID=40&md5=3d872a23a42099c31f2c65b9f480d310

Files